ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of Section 122 (3)(b) of the Companies Act and Section 6.54 of the JSE Listings Requirements

Notification in terms of Section 122 (3)(b) of the Companies Act and Section 6.54 of the JSE Listings Requirements

ASPEN PHARMACARE HOLDINGS LIMITED (“the Company”)
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94

NOTIFICATION IN TERMS OF SECTION 122 (3) OF THE COMPANIES ACT AND PARAGRAPH 6.54 OF THE JSE
LISTINGS REQUIREMENTS – DISPOSAL OF SECURITIES BY CORONATION ASSET MANAGEMENT PROPRIETARY LIMITED (“CORONATION”)

In accordance with section 122(3)(b) of the Companies Act, No. 71 of 2008, as amended (the “Act”), and
paragraph 6.54 of the JSE Listings Requirements, shareholders are hereby advised that the Company has
received formal notification that clients of Coronation have, in aggregate, disposed of an interest in the
ordinary shares of the Company, such that the total interest held by Coronation on behalf of its clients
amounts to 12.66% of the total issued ordinary shares of the Company.

As required in terms of section 122(3)(a) of the Act, the Company has filed the required notice with the
Takeover Regulation Panel.

The Board of the Company accepts responsibility for the information contained in this announcement and
confirms that, to the best of its knowledge and belief, the information is true and that this announcement
does not omit anything likely to affect the importance of the information included.



Durban
10 November 2026


Sponsor
Investec Bank Limited
Date: 10/11/2026 03:50:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.